Literature DB >> 8263194

Opacification of Middlebrook agar as an aid in identification of Nocardia farcinica.

M Flores1, E Desmond.   

Abstract

One hundred twenty seven human isolates of Nocardia asteroides complex were identified to the species level by drug susceptibility testing, acetamide utilization, thermotolerance studies, studies of arylsulfatase activity, and studies of acid production from rhamnose. N. asteroides complex organisms which were not identifiable as N. farcinica or N. nova were designated N. asteroides sensu stricto. All of the N. farcinica isolates and none of the other isolates produced a milky-white opacity surrounding colonies on Middlebrook 7H10 agar. This finding may facilitate the identification of N. farcinica.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8263194      PMCID： PMC266204          DOI： 10.1128/jcm.31.11.3040-3041.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  L-dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice.

Authors:  S Kohbata; B L Beaman
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

2.  Mouse pathogenicity studies of Nocardia asteroides complex species and clinical correlation with human isolates.

Authors:  E P Desmond; M Flores
Journal:  FEMS Microbiol Lett       Date:  1993-07-01       Impact factor: 2.742

3.  Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica.

Authors:  R J Wallace; M Tsukamura; B A Brown; J Brown; V A Steingrube; Y S Zhang; D R Nash
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  Clinical and laboratory features of Nocardia nova.

Authors:  R J Wallace; B A Brown; M Tsukamura; J M Brown; G O Onyi
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

Review 5.  Review of nocardial infections in France 1987 to 1990.

Authors:  P Boiron; F Provost; G Chevrier; B Dupont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267
  5 in total
  7 in total

1.  Identification of medically relevant Nocardia species with an abbreviated battery of tests.

Authors:  Deanna L Kiska; Karen Hicks; David J Pettit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Diagnosis of tuberculosis by trained African giant pouched rats and confounding impact of pathogens and microflora of the respiratory tract.

Authors:  Georgies F Mgode; Bart J Weetjens; Thorben Nawrath; Christophe Cox; Maureen Jubitana; Robert S Machang'u; Stéphan Cohen-Bacrie; Marielle Bedotto; Michel Drancourt; Stefan Schulz; Stefan H E Kaufmann
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

3.  Fatty acid characterization of rapidly growing pathogenic aerobic actinomycetes as a means of identification.

Authors:  A McNabb; R Shuttleworth; R Behme; W D Colby
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Severe keratitis due to Nocardia farcinica.

Authors:  C A Eggink; P Wesseling; P Boiron; J F Meis
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Use of the BioMerieux ID 32C yeast identification system for identification of aerobic actinomycetes of medical importance.

Authors:  D B Muir; R C Pritchard
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

Review 6.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  Opacification of Middlebrook agar as an aid in distinguishing Nocardia farcinica within the Nocardia asteroides complex.

Authors:  M Carson; A Hellyar
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.